Lipidated amide-based insulin prodrugs
US10385107B2 · kind B2 · utility
0Cited by
18References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2015 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Sep 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prodrug formulations of insulin and insulin analogs are provided wherein the insulin peptide has been modified by an amide bond linkage of a dipeptide prodrug element. The prodrugs disclosed herein have extended half-lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.